[1]
Petrelli, F., Caraffa, A., Scuri, S., Grappasonni, I., Magrini, E. and Cocchini, A. 2019. The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices. Acta Bio Medica Atenei Parmensis. 90, 2 (May 2019), 288-299. DOI:https://doi.org/10.23750/abm.v90i2.8340.